Breast cancer is the second most common malignancy among women in the United States. As such, the COVID-19 pandemic has caused medical facilities to change their methods of operation since March of 2020, including changes in diagnosis and treatment plans. New York (NY) has an unusually high incidence of breast cancer. This study analyzed the effects of the COVID-19 pandemic on breast cancer care (BCC) in NY. Women in NY that were diagnosed with or in remission for breast cancer were asked to take an online, anonymous survey regarding their BCC experience. For patients in treatment, 26% of women wished they had greater emotional support or had a family member included in their appointments. 39% of women do not feel they are receiving as good of care as before, while 31% feel they are receiving the same level of care. Additionally, 41% of women feel they received the same level of care over telemedicine. Our data show a negative correlation between the quality of care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). There was less of a negative correlation between the quality of telemedicine care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). This indicates that most women lacking emotional support reported worse BCC experiences, and telemedicine use was not as troublesome to patients as the lack of emotional support. Most women in treatment and in remission reported negative feelings like fear when asked about their BCC experiences. Our data show the importance of emotional support for breast cancer patients and those in remission during the COVID-19 pandemic. Our work could also provide clinicians with the knowledge necessary on how breast cancer care should be handled in an evolving pandemic such as COVID-19.
| Published in | American Journal of Biomedical and Life Sciences (Volume 10, Issue 3) |
| DOI | 10.11648/j.ajbls.20221003.11 |
| Page(s) | 58-64 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Breast Cancer, COVID-19, Breast Cancer Care, Breast Cancer Treatment, Breast Cancer Remission, Survey Analysis, Word-Emotion Association Lexicon, Pandemic Cancer Care
| [1] | Gathani T, Clayton G, MacInnes E, Horgan K. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020. British Journal of Cancer. 2021; 124: 710–712. https://www.nature.com/articles/s41416-020-01182-z. doi: 10.1038/s41416-020-01182-z. |
| [2] | Sharpless NE. COVID-19 and cancer. Science. 2020; 368 (6497): 1290–1290. https://science.sciencemag.org/content/368/6497/1290. doi: 10.1126/science.abd3377. |
| [3] | Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modeling study. The Lancet Oncology. 2020; 21 (8): 1023–1034. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30388-0/fulltext. doi: 10.1016/S1470-2045(20)30388-0. |
| [4] | Breastcancer.org. Special Report: COVID-19’s Impact on Breast Cancer Care. Breastcancer.org. 2020 Dec 17. https://www.breastcancer.org/treatment/covid-19-and-breast-cancer-care |
| [5] | Nagar H, Formenti SC. Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy. Nature Reviews Clinical Oncology. 2020; 17 (6): 332–334. doi: 10.1038/s41571-020-0375-1. |
| [6] | Uwins C, Bhandoria GP, Shylasree T, Butler-Manuel S, Ellis P, Chatterjee J, Tailor A, Stewart A, Michael A. COVID-19 and gynecological cancer: a review of the published guidelines. International Journal of Gynecologic Cancer. 2020; 30: ijgc-2020-001634. doi: 10.1136/ijgc-2020-001634. |
| [7] | Gebbia V, Piazza D, Valerio MR, Borsellino N, Firenze A. Patients With Cancer and COVID-19: A WhatsApp Messenger-Based Survey of Patients’ Queries, Needs, Fears, and Actions Taken. JCO Global Oncology. 2020; 6: GO. 20.00118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271316/. doi: 10.1200/GO.20.00118. |
| [8] | National Cancer Institute. Breast Cancer Statistics | EGRP/DCCPS/NCI/NIH. epi.grants.cancer.gov. https://epi.grants.cancer.gov/past-initiatives/libcsp/stats.html |
| [9] | Chynoweth J, McCambridge MM, Zorbas HM, Elston JK, Thomas RJS, Glasson WJH, Coutts JM, Daveson BA, Whitfield KM. Optimal Cancer Care for Aboriginal and Torres Strait Islander People: A Shared Approach to System Level Change. JCO Global Oncology. 2020; 6: 108–114. doi: 10.1200/jgo.19.00076. |
| [10] | Ristevski E, Thompson S, Kingaby S, Nightingale C, Iddawela M. Understanding Aboriginal Peoples’ Cultural and Family Connections Can Help Inform the Development of Culturally Appropriate Cancer Survivorship Models of Care. JCO Global Oncology. 2020; 6: 124–132. doi: 10.1200/jgo.19.00109. |
| [11] | Palmer Kelly E, Meara A, Hyer M, Payne N, Pawlik TM. Characterizing Perceptions Around the Patient-Oncologist Relationship: a Qualitative Focus Group Analysis. Journal of Cancer Education. 2019; 35. doi: 10.1007/s13187-019-1481-6. |
| [12] | ŞİRİNOĞLU DEMİRİZ I, GÜMÜŞEL C. Is There an Impact of Family Support on Treatment in Young Hodgkin’s Lymphoma Patients? EURAS Journal of Health. 2020 [accessed 2022 Mar 9]; 2 (2): 105–112. doi: 10.17932/ejoh.2020.022/ejoh_v02i2002. |
| [13] | Edge R, Meyers J, Tiernan G, Li Z, Schiavuzzi A, Chan P, Vassallo A, Morrow A, Mazariego C, Wakefield CE, et al. Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective Cheong MWL, editor. PLOS ONE. 2021; 16 (9): e0257420. doi: 10.1371/journal.pone.0257420. |
| [14] | Yildiz F, Oksuzoglu B. Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? Future Oncology. 2020; 16 (28). doi: 10.2217/fon-2020-0714. |
| [15] | Burbury K, Wong Z, Yip D, Thomas H, Brooks P, Gilham L, Piper A, Solo I, Underhill C. Telehealth in cancer care: during and beyond the COVID-19 pandemic. Internal Medicine Journal. 2021; 51 (1): 125–133. doi: 10.1111/imj.15039. |
| [16] | Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Research and Treatment. 2020; 184: 249–254. doi: 10.1007/s10549-020-05828-7. |
| [17] | Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nature Cancer. 2020; 1 (6): 565–567. doi: 10.1038/s43018-020-0074-y. |
| [18] | Juanjuan L, Santa-Maria CA, Hongfang F, Lingcheng W, Pengcheng Z, Yuanbing X, Yuyan T, Zhongchun L, Bo D, Meng L, et al. Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study. Clinical Breast Cancer. 2020; 20 (5): e651–e662. doi: 10.1016/j.clbc.2020.06.003. |
| [19] | Massicotte V, Ivers H, Savard J. COVID-19 Pandemic Stressors and Psychological Symptoms in Breast Cancer Patients. Current Oncology. 2021; 28 (1): 294–300. doi: 10.3390/curroncol28010034. |
| [20] | Savard J, Jobin-Théberge A, Massicotte V, Banville C. How did women with breast cancer experience the first wave of the COVID-19 pandemic? A qualitative study. Supportive Care in Cancer. 2021; 29. doi: 10.1007/s00520-021-06089-w. |
| [21] | Chen X, Wang L, Liu L, Jiang M, Wang W, Zhou X, Shao J. Factors associated with psychological distress among patients with breast cancer during the COVID-19 pandemic: a cross-sectional study in Wuhan, China. Supportive Care in Cancer. 2021; 29. doi: 10.1007/s00520-021-05994-4. |
| [22] | Papautsky EL, Hamlish T. Emotional Response of US Breast Cancer Survivors During the COVID-19 Pandemic. Cancer Investigation. 2020 Oct 23: 1–13. doi: 10.1080/07357907.2020.1841220. |
| [23] | Bartmann C, Fischer L-M, Hübner T, Müller-Reiter M, Wöckel A, McNeill RV, Schlaiss T, Kittel-Schneider S, Kämmerer U, Diessner J. The effects of the COVID-19 pandemic on psychological stress in breast cancer patients. BMC Cancer. 2021; 21 (1). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719114/. doi: 10.1186/s12885-021-09012-y. |
| [24] | Choobin MH, Mirabolfathi V, Chapman B, Moradi AR, Grunfeld EA, Derakshan N. The Impact of COVID-19 Outbreak on Emotional and Cognitive Vulnerability in Iranian Women with Breast Cancer. Frontiers in Psychology. 2021; 12. doi: 10.3389/fpsyg.2021.663310. |
| [25] | Hamlish T, Papautsky EL. Differences in Emotional Distress Among Black and White Breast Cancer Survivors During the COVID-19 Pandemic: a National Survey. Journal of Racial and Ethnic Health Disparities. 2021; 9. doi: 10.1007/s40615-021-00990-0. |
APA Style
Alexandra Fiederlein, Cheyenne Rosado, Noelle Cutter. (2022). Changes in Breast Cancer Care in New York During the COVID-19 Pandemic. American Journal of Biomedical and Life Sciences, 10(3), 58-64. https://doi.org/10.11648/j.ajbls.20221003.11
ACS Style
Alexandra Fiederlein; Cheyenne Rosado; Noelle Cutter. Changes in Breast Cancer Care in New York During the COVID-19 Pandemic. Am. J. Biomed. Life Sci. 2022, 10(3), 58-64. doi: 10.11648/j.ajbls.20221003.11
AMA Style
Alexandra Fiederlein, Cheyenne Rosado, Noelle Cutter. Changes in Breast Cancer Care in New York During the COVID-19 Pandemic. Am J Biomed Life Sci. 2022;10(3):58-64. doi: 10.11648/j.ajbls.20221003.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajbls.20221003.11,
author = {Alexandra Fiederlein and Cheyenne Rosado and Noelle Cutter},
title = {Changes in Breast Cancer Care in New York During the COVID-19 Pandemic},
journal = {American Journal of Biomedical and Life Sciences},
volume = {10},
number = {3},
pages = {58-64},
doi = {10.11648/j.ajbls.20221003.11},
url = {https://doi.org/10.11648/j.ajbls.20221003.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20221003.11},
abstract = {Breast cancer is the second most common malignancy among women in the United States. As such, the COVID-19 pandemic has caused medical facilities to change their methods of operation since March of 2020, including changes in diagnosis and treatment plans. New York (NY) has an unusually high incidence of breast cancer. This study analyzed the effects of the COVID-19 pandemic on breast cancer care (BCC) in NY. Women in NY that were diagnosed with or in remission for breast cancer were asked to take an online, anonymous survey regarding their BCC experience. For patients in treatment, 26% of women wished they had greater emotional support or had a family member included in their appointments. 39% of women do not feel they are receiving as good of care as before, while 31% feel they are receiving the same level of care. Additionally, 41% of women feel they received the same level of care over telemedicine. Our data show a negative correlation between the quality of care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). There was less of a negative correlation between the quality of telemedicine care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). This indicates that most women lacking emotional support reported worse BCC experiences, and telemedicine use was not as troublesome to patients as the lack of emotional support. Most women in treatment and in remission reported negative feelings like fear when asked about their BCC experiences. Our data show the importance of emotional support for breast cancer patients and those in remission during the COVID-19 pandemic. Our work could also provide clinicians with the knowledge necessary on how breast cancer care should be handled in an evolving pandemic such as COVID-19.},
year = {2022}
}
TY - JOUR T1 - Changes in Breast Cancer Care in New York During the COVID-19 Pandemic AU - Alexandra Fiederlein AU - Cheyenne Rosado AU - Noelle Cutter Y1 - 2022/05/10 PY - 2022 N1 - https://doi.org/10.11648/j.ajbls.20221003.11 DO - 10.11648/j.ajbls.20221003.11 T2 - American Journal of Biomedical and Life Sciences JF - American Journal of Biomedical and Life Sciences JO - American Journal of Biomedical and Life Sciences SP - 58 EP - 64 PB - Science Publishing Group SN - 2330-880X UR - https://doi.org/10.11648/j.ajbls.20221003.11 AB - Breast cancer is the second most common malignancy among women in the United States. As such, the COVID-19 pandemic has caused medical facilities to change their methods of operation since March of 2020, including changes in diagnosis and treatment plans. New York (NY) has an unusually high incidence of breast cancer. This study analyzed the effects of the COVID-19 pandemic on breast cancer care (BCC) in NY. Women in NY that were diagnosed with or in remission for breast cancer were asked to take an online, anonymous survey regarding their BCC experience. For patients in treatment, 26% of women wished they had greater emotional support or had a family member included in their appointments. 39% of women do not feel they are receiving as good of care as before, while 31% feel they are receiving the same level of care. Additionally, 41% of women feel they received the same level of care over telemedicine. Our data show a negative correlation between the quality of care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). There was less of a negative correlation between the quality of telemedicine care received during the pandemic and the wish for more emotional support and inclusion of supportive members in the care process (nonsignificant). This indicates that most women lacking emotional support reported worse BCC experiences, and telemedicine use was not as troublesome to patients as the lack of emotional support. Most women in treatment and in remission reported negative feelings like fear when asked about their BCC experiences. Our data show the importance of emotional support for breast cancer patients and those in remission during the COVID-19 pandemic. Our work could also provide clinicians with the knowledge necessary on how breast cancer care should be handled in an evolving pandemic such as COVID-19. VL - 10 IS - 3 ER -
Email: